Is there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC?

dc.contributor.authorKilickap, S.
dc.contributor.authorBasal, F. Bugdayci
dc.contributor.authorDemirkazik, A.
dc.contributor.authorGursoy, P.
dc.contributor.authorDemirci, U.
dc.contributor.authorErman, M.
dc.contributor.authorYumuk, F.
dc.contributor.authorSenler, F. Cay
dc.contributor.authorCakar, B.
dc.contributor.authorCicin, I.
dc.contributor.authorOzturk, A.
dc.contributor.authorCoskun, H. S.
dc.contributor.authorCubukcu, E.
dc.contributor.authorIsikdogan, A.
dc.contributor.authorOlmez, O. F.
dc.contributor.authorTatli, A. M.
dc.contributor.authorKaraagac, M.
dc.contributor.authorSakalar, T.
dc.contributor.authorEralp, Y.
dc.contributor.authorKorkmaz, T.
dc.date.accessioned2025-10-16T15:22:41Z
dc.date.issued2019
dc.description.abstract44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, SEP 27-OCT 01, 2019
dc.identifier.otherWOS:000491295504209
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7871
dc.publisherOXFORD UNIV PRESS
dc.sourceANNALS OF ONCOLOGY
dc.titleIs there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC?
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar